In the June edition of the Dark Report, Jason Bush, Ph.D., Avalon EVP, Product, shares his predictions on the need for better data regarding the accuracy and clinical relevance of genetic tests across labs and health plans and how Avalon and Optum are offering a different approach to managing genetic test claims to reduce the burden of prior auth and ensure the right test, for the right care and right reimbursement from a keynote at the Executive War College.
Read the full article at The Dark Report.
